Higher exposures erode specificity, and JAK2 inhibition by pan-JAK inhibitors frequently results in dose-dependent anaemia, highlighting the link between JAK2 signalling and erythropoiesis. The gene discussed is JAK2; the disease is anemia (phenotype).